Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002422852 | SCV002728164 | likely benign | Cardiovascular phenotype | 2018-04-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV002541283 | SCV003462505 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2022-05-17 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001794987 | SCV002034165 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001794987 | SCV002038084 | likely benign | not provided | no assertion criteria provided | clinical testing |